JC4.F UNIVERSAL IBOGAINE INC.

Healthcare Biotechnology Frankfurt Exchange
0.0035 EUR
Close of Nov 12, 2026
0.0005 0.0145
Market cap
EUR 1.10M
P/E
-
P/B
6.59x
ROE
-351.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Apr 2025.

Is JC4.F undervalued?

Graham number

The Graham number of UNIVERSAL IBOGAINE INC. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

UNIVERSAL IBOGAINE INC. fundamental analysis

No fundamental analysis for UNIVERSAL IBOGAINE INC. yet.

UNIVERSAL IBOGAINE INC. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About UNIVERSAL IBOGAINE INC.

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.

Full company profile